William D Tap1, Gary K Schwartz2. Show Affiliations » 1. Memorial Sloan-Kettering Cancer Center, New York, NY. 2. Memorial Sloan-Kettering Cancer Center, New York, NY schwartzg@columbia.edu.
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/administration & dosageBenzamides/administration & dosageBiomarkers, Tumor/analysisBiomarkers, Tumor/geneticsBiopsyChemotherapy, AdjuvantGastrectomyGastrointestinal Stromal Tumors/chemistryGastrointestinal Stromal Tumors/drug therapyGastrointestinal Stromal Tumors/geneticsGastrointestinal Stromal Tumors/pathologyGastrointestinal Stromal Tumors/surgeryHumansImatinib MesylateImmunohistochemistryMaleMiddle AgedMitotic IndexMultimodal ImagingMutationNeoplasm StagingPatient SelectionPiperazines/administration & dosagePositron-Emission TomographyPrecision MedicinePredictive Value of TestsProtein Kinase Inhibitors/administration & dosageProto-Oncogene Proteins B-raf/geneticsProto-Oncogene Proteins c-kit/analysisProto-Oncogene Proteins c-kit/geneticsPyrimidines/administration & dosageReceptor, Platelet-Derived Growth Factor alpha/geneticsRisk FactorsStomach Neoplasms/chemistryStomach Neoplasms/drug therapyStomach Neoplasms/geneticsStomach Neoplasms/pathologyStomach Neoplasms/surgeryTomography, X-Ray ComputedTreatment Outcome
Substances: See more » Antineoplastic AgentsBenzamidesBiomarkers, TumorPiperazinesProtein Kinase InhibitorsPyrimidinesImatinib MesylateProto-Oncogene Proteins c-kitReceptor, Platelet-Derived Growth Factor alphaBRAF protein, humanProto-Oncogene Proteins B-raf
Year: 2014 PMID: 24638004 DOI: 10.1200/JCO.2013.53.5971
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544